Mkhize: Covid-19 vaccine to target two-thirds of the population as govt aims for herd immunity

accreditation
0:00
play article
Subscribers can listen to this article
Health minister Zweli Mkhize.
Health minister Zweli Mkhize.
Lulama Zenzile
  • South Africa is currently in discussions with pharmaceutical companies to ensure enough Covid-19 vaccines to immunise 67% of the population.
  • The vaccines will be rolled out in a phased approach, with healthcare workers and essential workers first in line to receive their jabs.
  • The vaccines are expected to be available in the second quarter of the year, but it may be sooner depending on agreements with manufacturers.

At least 67% of South Africans will need to be vaccinated against Covid-19 to ensure herd immunity, health minister Zweli Mkhize has announced during a public briefing.

On Sunday, Mkhize unveiled the government's strategy to secure vaccines and roll them out to two-thirds of South Africa's 57 million citizens, saying the government was currently in discussions with several manufacturers.

The vaccine is expected to be rolled out in three phases, with the 1.25 million healthcare workers in the country having first access.

A second phase will see essential workers - such as miners, teachers and police officers - and those living in congregate settings, such as care centres and prisons, offered the vaccine. The second phase, which will require roughly 16 million vaccines, will also include those over 60 and those with comorbidities.

READ | Covid-19: Here are the latest rules as SA reverts to Level 3

The third phase will see vaccines being made available to an additional 40 million citizens.

Mkhize added the Covax agreement would see enough vaccines to cover 10% of the population delivered by the second quarter of 2021, but enough vaccines to cover the remaining 57% of the population would have to be sourced through bilateral agreements.

The government is currently in discussions with several pharmaceutical companies, including Pfizer, Moderna, Johnson and Johnson, and Astra Zenca.

He said non-disclosure agreements had been signed with these companies, meaning the government was able to share only limited information on the discussions.

According to the deputy director-general of the health department, Dr Anban Pillay who spoke at the briefing, these discussions could result in vaccines being delivered in the first quarter of the year.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Results
Nkosazana Dlamini-Zuma has got it in the bag
7% - 617 votes
I foresee a second term for Cyril Ramaphosa
83% - 7403 votes
Don’t discount a Zweli Mkhize win
10% - 921 votes
Vote
Rand - Dollar
17.62
+1.2%
Rand - Pound
20.23
-0.2%
Rand - Euro
17.60
-0.4%
Rand - Aus dollar
11.43
+1.7%
Rand - Yen
0.12
+0.8%
Gold
1,725.29
+1.5%
Silver
21.07
+1.7%
Palladium
2,312.17
+3.9%
Platinum
934.41
+3.3%
Brent Crude
88.86
+4.2%
Top 40
59,840
+3.3%
All Share
66,313
+3.2%
Resource 10
64,568
+4.5%
Industrial 25
80,073
+3.2%
Financial 15
14,053
+1.7%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE